New pill shows promise in hard-to-treat cancers
CHICAGO (Reuters) - An experimental cancer pill made by Roche's Genentech shrank tumors in patients whose skin cancer had spread, raising hope for a new class of drugs that may have an affect on many other cancers as well, U.S. researchers said ...